)
Peptonic Medical (PMED) investor relations material
Peptonic Medical Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Sales of goods decreased by 52% to 2,360 KSEK in Q2 2026 compared to Q2 2025, with a gross margin of 60% versus 97% last year.
Operating loss widened slightly to -3,711 KSEK in Q2 2026 from -3,489 KSEK in Q2 2025.
Strategic focus sharpened post-restructuring, with reduced cost base and new product launches supporting growth ambitions.
First commercial delivery to a US partner marks a milestone in international expansion.
Financial highlights
Q2 2026 sales: 2,360 KSEK (down from 4,912 KSEK in Q2 2025); H1 2026 sales: 5,498 KSEK (down from 8,670 KSEK in H1 2025).
Gross profit in Q2 2026: 1,415 KSEK (Q2 2025: 4,783 KSEK); gross margin 60% (Q2 2025: 97%).
Operating expenses in Q2 2026: -6,577 KSEK, down 32% year-over-year.
Net result for Q2 2026: -3,837 KSEK (Q2 2025: -3,535 KSEK).
Cash at June 30, 2026: 758 KSEK (June 30, 2025: 5,667 KSEK).
Outlook and guidance
Focus remains on product development, sales growth, and brand building.
Updated CE marking for Vernivia expected in autumn, enabling relaunch.
Strengthened financial position and lower cost base support continued commercial development.
- Operating loss narrowed and gross margin improved in Q1 2026 after restructuring and new product launches.PMED
Q1 2026 - Restructuring and cost control drove profitability gains amid lower sales and international expansion.PMED
Q4 2025 - Restructuring led to lower sales but improved cost efficiency; new US/UK deal boosts outlook.PMED
Q3 2025 - Cost cuts and margin gains halved losses, with break-even targeted for November 2025.PMED
Q2 2025 - Revenue declined but gross margin and Nordic sales improved as US direct launch began.PMED
Q3 2024 - Nordic sales surged 60% while group revenue fell; liquidity boosted by post-period rights issue.PMED
Q2 2024 - Restructuring and new launches drive Peptonic's Q1, with improved margins despite lower sales.PMED
Q1 2025 - Nordic sales up 76% and US launch underway, with improved margins and new financing secured.PMED
Q4 2024
Next Peptonic Medical earnings date
Next Peptonic Medical earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)